Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer | Zendy

Wojciech Miltyk | Zendy; Corneliu N. Craciunescu | Zendy; Leslie M. Fischer | Zendy; Robert A Jeffcoat | Zendy; Matthew Koch | Zendy; Wlodek Lopaczynski | Zendy; Chrysa Mahoney | Zendy; James A. Crowell | Zendy; Jennifer Paglieri | Zendy; Steven H Zeisel | Zendy

Open Access

Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer

Author(s) -

Wojciech Miltyk,

Corneliu N. Craciunescu,

Leslie M. Fischer,

Robert A Jeffcoat,

Matthew Koch,

Wlodek Lopaczynski,

Chrysa Mahoney,

James A. Crowell,

Jennifer Paglieri,

Steven H Zeisel

Publication year - 2003

Publication title -

american journal of clinical nutrition

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.608

H-Index - 336

eISSN - 1938-3207

pISSN - 0002-9165

DOI - 10.1093/ajcn/77.4.875

Subject(s) - genistein , daidzein , glycitein , genotoxicity , prostate cancer , isoflavones , cancer , comet assay , dna damage , medicine , micronucleus test , chemistry , endocrinology , toxicity , dna , biochemistry

Genistein may be useful in the prevention or treatment of prostate cancer; however, it causes genetic damage in cultured human cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog